CIK 0000318154
- Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 953540776
- Phone
- +1 805-447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-06 | ISHRAK OMAR Director | Grant or award | +760 | 935 | ||
| 2021-08-06 | HOLLEY CHARLES M Director | Grant or award | +347.6 | 5,473.04 | ||
| 2021-05-18 | Druker Brian Director | Grant or award | +837 | 3,634 | ||
| 2021-05-18 | Williams R Sanders Director | Grant or award | +837 | 5,246 | ||
| 2021-05-18 | SUGAR RONALD D Director | Grant or award | +837 | 16,764 | ||
| 2021-05-18 | MILES AMY E Director | Grant or award | +837 | 1,245 | ||
| 2021-05-18 | Kullman Ellen Jamison Director | Grant or award | +837 | 7,930.62 | ||
| 2021-05-18 | Jacks Tyler Director | Grant or award | +837 | 12,410 | ||
| 2021-05-18 | HOLLEY CHARLES M Director | Grant or award | +837 | 5,093.44 | ||
| 2021-05-18 | Garland Greg C. Director | Grant or award | +837 | 9,861 | ||
| 2021-05-18 | ECKERT ROBERT Director | Grant or award | +837 | 13,199 | ||
| 2021-05-18 | Austin Wanda M Director | Grant or award | +837 | 4,031 | ||
| 2021-05-12 | SUGAR RONALD D Director | Exercise or conversion | +1,000 | $71.64 | $72K | 16,927 |
| 2021-05-12 | SUGAR RONALD D Director | Sale | −1,000 | $250.59 | $251K | 15,927 |
| 2021-05-12 | SUGAR RONALD D Director | Exercise or conversion · Nqso (Right to Buy) | −1,000 | 0 | ||
| 2021-05-11 | Grygiel Nancy A. SVP & CCO | Exercise or conversion | +2,500 | $162.60 | $407K | 14,961 |
| 2021-05-11 | Grygiel Nancy A. SVP & CCO | Sale | −2,500 | $252.51 | $631K | 12,461 |
| 2021-05-11 | Grygiel Nancy A. SVP & CCO | Exercise or conversion · Nqso (Right to Buy) | −2,500 | 1,639 | ||
| 2021-05-07 | Williams R Sanders Director | Sale | −250 | $251.78 | $63K | 4,409 |
| 2021-05-03 | Santos Esteban EVP, Operations | Shares withheld for taxes | −685 | $239.64 | $164K | 51,108 |
Page 30 of 35 · 698 trades